NCT05605184

Brief Summary

Breast cancer patients complete questionnaires concerning their use of medical apps.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2022

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

August 12, 2022

Completed
3 months until next milestone

First Posted

Study publicly available on registry

November 4, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2023

Completed
2.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2025

Completed
Last Updated

November 22, 2024

Status Verified

November 1, 2024

Enrollment Period

7 months

First QC Date

August 12, 2022

Last Update Submit

November 19, 2024

Conditions

Health Care Survey

Outcome Measures

Primary Outcomes (1)

  • The attitudes of breast cancer patients regarding the use of medical apps: a survey-based study

    Evaluation of relative frequency of answers in the questionnaire regarding patient's approach to app-utility

    6 Months

Study Arms (1)

Survey

Breast cancer patients complete questionnaire concerning their use of medical apps.

Other: Survey

Interventions

SurveyOTHER

Survey

Survey

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Breast cancer patients at TUM Department of Gynecology and Obstetrics

You may qualify if:

  • breast cancer patients
  • patients who are legally competent and able to understand and follow instructions of the study staff

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Klinikum rechts der Isar, Frauenklinik, Technische Universität München

Munich, Germany, 81675, Germany

Location

MeSH Terms

Interventions

Surveys and Questionnaires

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Heike Jansen, Dr. med.

    Technical University of Munich

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 12, 2022

First Posted

November 4, 2022

Study Start

July 1, 2022

Primary Completion

January 31, 2023

Study Completion

March 31, 2025

Last Updated

November 22, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations

DE(1)